Efficacy and safety of enzymatic formulation of amoxicillin/ clavulanic acid compared to conventional amoxicillin/ clavulanic acid in the treatment of upper respiratory tract infections in children: A post marketing surveillance study
Journal Title: The Indian Practitioner - Year 2016, Vol 68, Issue 11
Abstract
Background: Conventional amoxicillin produced on industrial scale is made using a chemical process with use of solvents. These solvents are present in the final formulation of amoxicillin and may lead to increased chance of side effects, namely diarrhea and abdominal pain. On the other hand, enzymatic amoxicillin, is made with the help of enzymes instead of the chemical solvents, and this results in purer amoxicillin, which may have lesser chances of side effects. Objective: The purpose of this study was to explore the safety and efficacy of ‘enzymatic formulation’ of amoxicillin and Clavulanic acid (400 mg/57 mg) suspension compared to ‘conventional formulation’ of amoxicillin and Clavulanic acid (400 mg/57 mg) for 7 days in treatment of upper respiratory tract infections in pediatric patients. Methods: This was an open-label prospective study comparing ‘enzymatic formulation’ of amoxicillin/Clavulanic acid (enzymatic formulation group) with ‘conventional formulation’ of amoxicillin/Clavulanic acid (conventional formulation group) in a 1:1 ratio in pediatric patients with upper respiratory tract infections. The treatment duration was for 7 days, and the patient was followed up on Day 3 (Visit 2) and at end of the treatment (Visit 3). Efficacy was assessed based on Physicians assessment of Clinical response at Visit 2 and Visit 3 defined as ‘Cure’: Disappearance of clinical signs and symptoms within the treatment period, ‘Improved’: Subsiding of clinical signs and symptoms but with incomplete resolution and ‘Treatment Failure’: Unchanged or worsening of baseline clinical signs and symptoms. Tolerability was evaluated based on Investigators’ assessment on patient response, and classified as: ‘Good tolerability’: Side effects mild or not observed, ‘Moderate tolerability’: Side effects of moderate intensity, ‘Poor tolerability’: Side effects severe or discontinuation because of side effects. Safety was assessed for occurrence of any adverse events namely diarrhea and abdominal pain. Results: In all 100 pediatric patients with upper respiratory tract infections like acute otitis media, Tonsilitis and sinusitis, were equally randomized to enzymatic formulation group (n = 50) and conventional formulation group (n = 50). Treatment duration was for 7 days and the average age was 4 years of which 28 were females and 68 were males. The primary efficacy end point of ‘Physicians overall assessment’ of ‘Improved’ and ‘Cure’ though not statistically significant was better in patients receiving enzymatic formulation at Visit 2 and Visit 3, respectively, was 100% (50) with enzymatic formulation group as compared to 96% (48) in the conventional group. ‘Moderate tolerability’ was seen in only 2% (1) in enzymatic formulation group as compared to 6% (3) of patients in conventional formulation group at visit 2; On visit 3 ‘Moderate tolerability’ was seen in 6% (3) of patients in conventional formulation only. ‘Poor tolerability’ was seen in 4% (2) of patients in conventional formulation group only on visit 2. Overall adverse events reported in the enzymatic formulation group and conventional group was 4% (2) and 20% (10) respectively. Incidence of adverse event namely diarrhea and abdominal pain on Visit 2, was seen in 2% (1) patients on enzymatic formulation group as compared to 14% (7) in the conventional group; and on Visit 3, was seen in 2% (1) of patients on enzymatic formulation group as compared to 6% (3) in the conventional group. Treatment failure was noted in 2 patients in the conventional formulation group. The difference in the tolerability parameters was not statistically significant. Conventional formulation was discontinued on visit 2 in one patient due to poor tolerability and diarrhea. Conclusion: ‘Enzymatic formulation’ of amoxicillin-clavulanic acid provided similar clinical response of ‘Improvement’ and ‘Cure’ with good tolerability and lesser incidence of diarrhea and abdominal pain, as compared to the ‘conventional formulation’ of amoxicillin-clavulanic acid.
Authors and Affiliations
S Tadvi, M Zakhariya, S M Mane
Keywords
Related Articles
- EP ID EP586069
- DOI -
- Views 51
- Downloads 0
Coexistence of Persistent Ductus Caroticus And Ductus Arteriosus
The authors describe what is, to their knowledge a case of coexistence of ductus caroticus and ductus arteriosus along with tetralogy of Fallot. The ductus caroticus is manifested as low lying carotid artery origin at C6...
Indeterminate Pulmonary Nodule: An assessment from a Surgeon’s perspective
Background: Finding of pulmonary nodule in chest X-ray or CT scan during routine investigations or during surveillance for metastasis, in known case of malignancy is not an uncommon occurrence. Even after all routine eva...
STI/STDs in adolescents: Prevalence, Consequences, Causes & Diagnosis
The prevalence of Sexually Transmitted Infections (STDs) is rising all over the world and also in India. Due to the possible serious consequences in a substantial proportion like infertility, pelvic inflammation or life...
Atherosclerotic Aortic Aneurysm An unusual cause of Spastic Paraparesis
Aortic aneurysm causing bone erosion is uncommon and is rarely associated with neurological deficits. Only few cases have been reported. We report a case of atherosclerotic aneurysm of the descending thoracic aorta causi...
Trichosporon beigelli infection a child with congenital extrophy bladder
no abstract